Optimark and Monopril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Optimark (gadoversetamide) and Monopril (fosinopril sodium). Common drug interactions include acne among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Optimark and Monopril. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Optimark?

Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.

What is Monopril?

Monopril has active ingredients of fosinopril sodium. It is often used in high blood pressure. eHealthMe is studying from 5,910 Monopril users. Check the latest studies of Monopril.

On Aug, 02, 2026

21 people who take Optimark and Monopril together, and have interactions are studied.

Optimark and Monopril drug interactions.

What are the common drug interactions of Optimark and Monopril, by gender? *:

female:

Acne (skin problems that cause pimples)
Erythema (redness of the skin)
Laceration (tearing of soft body tissue)
Skin exfoliation (removal of the oldest dead skin cells)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin hypertrophy (skin cells enlarges)
Skin tightness
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Dry skin

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin discolouration (change of skin colour)
Deformity (disfigurement)
General physical health deterioration (weak health status)
Scar
Skin induration (an abnormally hard spot or area on the skin)
Arthralgia (joint pain)
Stasis dermatitis (skin inflammation caused by blood pooling in the veins in your legs)
Muscular weakness (muscle weakness)

What are the common drug interactions of Optimark and Monopril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Rash papular (redness with papule)
Rash pruritic (redness with itching)
Skin plaque (red, scaly patches to appear on the skin)
Subcutaneous nodule
Anxiety
Emotional distress
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin hyperpigmentation (disorders affect the colour of your skin)

40-49:

Alopecia (absence of hair from areas of the body)
Arthralgia (joint pain)
Deformity (disfigurement)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Joint swelling
Mobility decreased (ability to move is reduced)
Myosclerosis (hardening of muscle tissue)

50-59:

n/a

60+:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Stasis dermatitis (skin inflammation caused by blood pooling in the veins in your legs)
Arthralgia (joint pain)
Asthenia (weakness)
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Dysstasia (difficulty in standing)
Fatigue (feeling of tiredness)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 11 people, 52.38%
Phosphorus Metabolism Disorder: 3 people, 14.29%
Diabetes: 3 people, 14.29%
Depression: 3 people, 14.29%
Computerised Tomogram Abdomen: 3 people, 14.29%
Blood Phosphorus Abnormal: 3 people, 14.29%
Bleeding Disorders: 3 people, 14.29%
Anaemia Of Chronic Disease: 3 people, 14.29%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 9.52%
Stress And Anxiety: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Optimark and Monopril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously